Online citations, reference lists, and bibliographies.
← Back to Search

Extrapleural Pneumonectomy And Extended Pleurectomy/decortication For Malignant Pleural Mesothelioma: The Memorial Sloan-Kettering Cancer Center Approach.

V. Rusch
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Surgical management for malignant pleural mesothelioma (MPM) remains controversial, but because of the limitations of radiation and chemotherapy in this disease, surgery is still an important part of treatment for these patients (1-13). Operations for MPM can be categorized as those performed with either palliative or curative intent. Palliative procedures such as video-assisted thoracoscopy surgery (VATS) and talc pleurodesis control pleural effusions in patients whose overall medical condition precludes definitive resection (14). In such cases, thoracotomy and partial pleurectomy is indicated only when the pleural effusion is loculated and cannot be evacuated by VATS. Curative intent operations include extrapleural pneumonectomy (EPP) and extended pleurectomy/decortication (P/D). This article provides a brief review of preoperative evaluation and the surgical technique for EPP and P/D (15-17).
This paper references
10.1097/JTO.0b013e31826915f1
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
V. Rusch (2012)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1016/J.ATHORACSUR.2007.04.076
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
D. Rice (2007)
10.1016/J.JTCVS.2006.06.044
Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
M. D. de Perrot (2007)
10.1158/1078-0432.CCR-09-2313
A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters
A. Nowak (2010)
10.1016/S0003-4975(99)01038-3
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
V. Rusch (1999)
10.1016/J.EJCTS.2007.01.061
Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results.
J. Edwards (2007)
10.1097/JTO.0b013e31815608d9
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center
R. Flores (2007)
10.5761/ATCS.OA.10.01572
Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience.
T. Yan (2011)
10.Diffuse Malignant Mesotheliomaの1例(第721回 千葉医学会例会・第19回 肺癌研究施設例会)
光永 伸一郎 (1985)
10.2214/AJR.166.2.8553940
The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
E. Patz (1996)
10.1378/CHEST.122.6.2256
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy.
J. Byrne (2002)
10.1016/S0003-4975(99)01555-6
Latissimus dorsi reverse flap to substitute the diaphragm after extrapleural pneumonectomy.
A. Bedini (2000)
10.1016/S1077-9108(08)79041-8
Malignant Pleural Mesothelioma: Surgical Management in 285 Patients
P. Bejarano (2009)
10.1016/j.ejcts.2008.03.003
Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
C. Aigner (2008)
10.1016/j.jtcvs.2007.10.054
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
R. Flores (2008)
10.1097/SLA.0B013E3181CFDB49
General Thoracic Surgery, 7th ed.
T. Birdas (2010)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1097/JTO.0b013e3182208e3f
Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group
D. Rice (2011)
10.1016/J.EJCTS.2003.12.001
The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma.
J. Pilling (2004)
10.1183/09031936.00063109
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
10.1016/J.JTCVS.2004.10.034
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
J. Erasmus (2005)
10.1016/J.ATHORACSUR.2005.06.014
Extended surgical staging for potentially resectable malignant pleural mesothelioma.
D. Rice (2005)
10.1016/S0022-5223(19)35312-7
The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma.
V. Rusch (1988)
10.1007/BF02305768
Laparoscopy: An important tool in the staging of malignant pleural mesothelioma
K. Conlon (2006)
10.2214/AJR.172.4.10587144
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
R. Heelan (1999)
10.1016/S0022-5223(03)00207-1
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
R. Flores (2003)
10.1016/S0169-5002(07)70198-8
122 Risk factors for major complications after extrapleural pneumonectomy
M. Perrot (2006)
10.1016/j.hlc.2010.11.045
A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
C. Cao (2011)
10.1016/J.THORSURG.2004.06.001
Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications.
M. Chang (2004)
10.1016/j.jtcvs.2008.02.069
The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
R. Flores (2008)
10.1016/J.EJCTS.2007.01.064
Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
A. Martin-Ucar (2007)
10.1016/J.JTCVS.2006.03.068
Positron emission tomography predicts survival in malignant pleural mesothelioma.
R. Flores (2006)
10.1016/S0022-5223(96)70342-2
The importance of surgical staging in the treatment of malignant pleural mesothelioma.
V. Rusch (1996)
10.1016/B978-0-443-06861-4.50100-3
TECHNIQUE OF EXTRAPLEURAL PNEUMONECTOMY FOR MALIGNANT PLEURAL MESOTHELIOMA
V. Rusch (2008)
10.1016/j.jtcvs.2008.12.045
Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
T. Yan (2009)
10.1016/j.ejcts.2009.07.032
Three decades of experience in the surgical multi-modality management of pleural mesothelioma.
H. Luckraz (2010)
10.2214/AJR.159.5.1414807
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
E. Patz (1992)
10.1016/S0022-5223(19)36578-X
Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
D. Sugarbaker (1991)
Double unilateral thoracotomy for malignant pleural mesothelioma.
L. Politi (2004)
10.1016/j.ejcts.2010.12.024
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
D. Sugarbaker (2011)
10.1016/J.JTCVS.2005.11.044
The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma.
J. Edwards (2006)
10.1510/icvts.2010.262972
Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update.
C. Cao (2011)



This paper is referenced by
HMGB-1 Release and the CD8+ T Cell Response Elicited by Radiation Treatment in Malignant Pleural Mesothelioma
Matthew Wu (2015)
10.1111/ajco.12680
Intensity modulated radiation therapy after extra‐pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival
Sameer Jhavar (2018)
10.1016/j.athoracsur.2015.01.058
Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma.
D. Burkholder (2015)
10.1016/j.jtho.2016.04.028
Consensus Report of the 2015 Weinman International Conference on Mesothelioma
M. Carbone (2016)
10.1053/j.semtcvs.2014.08.003
Novel induction therapies for pleural mesothelioma.
L. Donahoe (2014)
10.1016/j.lungcan.2013.11.026
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
C. Cao (2014)
10.21037/shc.2018.05.06
Surgical technique of pleurectomy/decortication
Masaki Hashimoto (2018)
10.1016/j.thorsurg.2015.04.001
Great Vessel Injury in Thoracic Surgery.
M. Villa (2015)
10.1007/978-3-319-89893-3_10
Staging of Malignant Pleural Mesothelioma
P. Groot (2018)
10.18632/oncotarget.13174
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis
R. Bruno (2017)
10.1093/ejcts/ezw045
The management of the diaphragm during radical surgery for malignant pleural mesothelioma.
A. Sharkey (2016)
10.1007/978-1-4471-6404-3_51
Surgical and Medical Therapy for Malignant Pleural Mesothelioma
C. Cao (2014)
10.1007/s00104-016-0186-1
Chirurgische Therapie des malignen Pleuramesothelioms
M. Schirren (2016)
10.21037/jtd.2018.01.116
Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.
P. Filosso (2018)
10.2995/JACSURG.30.555
臓側胸膜に明らかな肉眼病変を認めない若年女性の悪性胸膜中皮腫に対するextended pleurectomy/decortication
由貴 中島 (2016)
10.1097/imi.0000000000000325
Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Novel Mini-Invasive Technique
F. Caronia (2016)
10.1016/j.jtcvs.2018.09.106
Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma
M. Hashimoto (2019)
10.2174/1874321801711010029
Clinical Pearls in Anaesthesia for Pleurectomy/Decortication for Malignant Mesothelioma
S. Shah (2017)
10.1007/s11748-014-0389-7
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma
S. Hasegawa (2014)
10.1016/S1470-2045(15)00208-9
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
R. Stahel (2015)
Semantic Scholar Logo Some data provided by SemanticScholar